The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 07, 2021

Filed:

Oct. 13, 2017
Applicant:

Jeju National University Industry-academic Cooperation Foundation, Eju-si, KR;

Inventors:

Dong-sun Lee, Jeju-si, KR;

Hack Sun Choi, Jeju-si, KR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/357 (2006.01); A61P 35/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/357 (2013.01); A61P 35/04 (2018.01);
Abstract

The present invention relates to a composition for inhibiting the growth of cancer stem cells, which includes ciclesonide or a pharmaceutically acceptable salt thereof as an active ingredient, a pharmaceutical composition or food composition for inhibiting cancer metastasis, or treating or preventing cancer, which includes the composition, and the like. Ciclesonide of the present invention inhibits the growth of breast cancer cells and lung cancer cells, and inhibits the formation of breast cancer stem cells and lung cancer stem cells. In addition, it was confirmed that ciclesonide inhibited the expression of self-renewing genes such as Nanog, C-myc, Oct4, Sox2, Snail, and CD44, which are known to be characteristically expressed in breast cancer stem cells and lung cancer stem cells, inhibited the production of IL-6 and IL-8, which are known to be involved in the formation of mammospheres of breast cancer stem cells and the formation of tumorspheres of lung cancer stem cells, and inhibited the STAT3 signaling pathway. Accordingly, the compound inhibits the growth of cancer stem cells such as breast cancer stem cells, lung cancer stem cells, and the like and the growth of these cancers, and thus may be used for the treatment of cancer such as breast cancer, lung cancer, and the like.


Find Patent Forward Citations

Loading…